Human-type sialic acid receptors contribute to avian influenza A virus binding and entry by hetero-multivalent interactions
Liu, Mengying; Huang, Liane Z X; Smits, Anthony A; Büll, Christian; Narimatsu, Yoshiki; van Kuppeveld, Frank J M; Clausen, Henrik; de Haan, Cornelis A M; de Vries, Erik
(2022) Nature Communications, volume 13, issue 1, pp. 1 - 12
(Article)
Abstract
Establishment of zoonotic viruses, causing pandemics like the Spanish flu and Covid-19, requires adaptation to human receptors. Pandemic influenza A viruses (IAV) that crossed the avian-human species barrier switched from binding avian-type α2-3-linked sialic acid (2-3Sia) to human-type 2-6Sia receptors. Here, we show that this specificity switch is however less
... read more
dichotomous as generally assumed. Binding and entry specificity were compared using mixed synthetic glycan gradients of 2-3Sia and 2-6Sia and by employing a genetically remodeled Sia repertoire on the surface of a Sia-free cell line and on a sialoglycoprotein secreted from these cells. Expression of a range of (mixed) 2-3Sia and 2-6Sia densities shows that non-binding human-type receptors efficiently enhanced avian IAV binding and entry provided the presence of a low density of high affinity avian-type receptors, and vice versa. Considering the heterogeneity of sialoglycan receptors encountered in vivo, hetero-multivalent binding is physiologically relevant and will impact evolutionary pathways leading to host adaptation.
show less
Download/Full Text
Keywords: Animals, COVID-19, Hemagglutinin Glycoproteins, Influenza Virus/metabolism, Humans, Influenza A virus/metabolism, Influenza Pandemic, 1918-1919, Influenza, Human, N-Acetylneuraminic Acid/metabolism, Receptors, Cell Surface/genetics, Receptors, Virus/metabolism, General, General Physics and Astronomy, General Chemistry, General Biochemistry,Genetics and Molecular Biology
ISSN: 2041-1723
Publisher: Nature Publishing Group
Note: Funding Information: Support by a personal grant from the Chinese Scholarship Council to ML was obtained (201908350116). Support by the Lundbeck Foundation, Novo Nordisk Foundation, and the Danish National Research Foundation was obtained (DNRF107L: C.B., Y.N and H.C.). Recombinant virus strains VI75, BK79, WU95 and FU02 were kindly provided by Dr. R. Fouchier (Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands). H5N8 was kindly provided by Wageningen Bioveterinary Research (Olaf de Leeuw, Ben Peeters and Riks Maas). Biotinylated synthetic glycans were kindly provided by Dr. Geert-Jan Boons (Utrecht University, Utrecht, the Netherlands). Figures 1 g, 3 a and 6 were created with BioRender.com Funding Information: Support by a personal grant from the Chinese Scholarship Council to ML was obtained (201908350116). Support by the Lundbeck Foundation, Novo Nordisk Foundation, and the Danish National Research Foundation was obtained (DNRF107L: C.B., Y.N and H.C.). Recombinant virus strains VI75, BK79, WU95 and FU02 were kindly provided by Dr. R. Fouchier (Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands). H5N8 was kindly provided by Wageningen Bioveterinary Research (Olaf de Leeuw, Ben Peeters and Riks Maas). Biotinylated synthetic glycans were kindly provided by Dr. Geert-Jan Boons (Utrecht University, Utrecht, the Netherlands). Figures g, a and were created with BioRender.com Publisher Copyright: © 2022, The Author(s).
(Peer reviewed)